Sinocare receives EU MDR certification for glucose monitoring system

Sinocare (SZSE:300298) announced that it has received Medical Device Regulation (MDR) certification from TÜV Rheinland for its latest continuous glucose monitoring system, marking a significant milestone for the company's European market strategy. The certified product, *Sinocare iCan Continuous Glucose Monitoring System*, includes Models i6, H6, i7 and H7. The GlucoMen® iCan Continuous Glucose Monitoring System applies to Model H6. The device, classified as a Class IIb product, received its certification on July 2, 2025, with an expiration date of September 27, 2028.